GUILFORD, Conn.–(BUSINESS WIRE)– February 18, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing single molecule protein sequencing, today announced that it will be participating virtually in the 42nd Annual Cowen Health Care Conference. Quantum-Si’s management is scheduled to present virtually on Tuesday, March 8, 2022 at 2:10 pm ET. A live […]
Founder and Executive Chairman of the Board to Advance Quantum-Si’s Protein Sequencing Technology and Commercialization Strategy GUILFORD, Conn.–(BUSINESS WIRE)– Feb. 14, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of Quantum Si’s Board of Directors, […]
GUILFORD, Conn.–(BUSINESS WIRE)– Feb. 07, 2022 — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that it will report fourth quarter and full year 2021 financial results after market close on Monday, February 28, 2022. Company management will host a conference call on the […]
GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference to be held virtually on January 10-13, 2022. Quantum-Si’s management is scheduled to present virtually on Wednesday, January 12, 2022 at […]
GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI). The addition is based on the results of the annual reconstitution of the index announced by Nasdaq on December 10, […]
Quantum-Si Continues Momentum and Accelerates Commercialization Efforts GUILFORD, Conn., November 10. Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced financial results for the quarter ended September 30, 2021 and provided a business update. Recent Highlights Expanded Early Access program to ten, with […]
Acquisition expands Quantum-Si’s capabilities in semiconductor chip assembly and packaging GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique single molecule protein sequencing platform, today announced that it acquired Majelac Technologies LLC, a privately-owned company providing semiconductor packaging and integrated circuit assembly services. The acquisition secures […]
GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat […]
GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq:QSI), a company pioneering next-generation semiconductor chip-based proteomics, today announced that it will report third quarter 2021 financial results on November 11, 2021, before market open. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will host a conference call and webcast at 8:30 a.m. ET on November 11, […]
GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life science tools company commercializing a unique protein sequencing platform, announced today that they have expanded their Platinum early access program to ten sites, with participation from leading academic centers and key industry partners. The early access program introduces the Platinum single molecule sequencing […]